BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26338254)

  • 1. Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
    Brisuda A; Pazourkova E; Soukup V; Horinek A; Hrbáček J; Capoun O; Svobodova I; Pospisilova S; Korabecna M; Mares J; Hanuš T; Babjuk M
    Urol Int; 2016; 96(1):25-31. PubMed ID: 26338254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
    Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
    Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
    Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
    Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
    Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.
    Zancan M; Galdi F; Di Tonno F; Mazzariol C; Orlando C; Malentacchi F; Agostini M; Maran M; Del Bianco P; Fabricio AS; Murer B; Pianon C; Gion M
    Int J Biol Markers; 2009; 24(3):147-55. PubMed ID: 19787625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data.
    Casadio V; Calistri D; Tebaldi M; Bravaccini S; Gunelli R; Martorana G; Bertaccini A; Serra L; Scarpi E; Amadori D; Silvestrini R; Zoli W
    Urol Oncol; 2013 Nov; 31(8):1744-50. PubMed ID: 23141783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method to preserve the original proportion and integrity of urinary cell-free DNA.
    Li P; Ning J; Luo X; Du H; Zhang Q; Zhou G; Du Q; Ou Z; Wang L; Wang Y
    J Clin Lab Anal; 2019 Feb; 33(2):e22668. PubMed ID: 30175467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
    Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA
    Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
    Ribal MJ; Mengual L; Lozano JJ; Ingelmo-Torres M; Palou J; Rodríguez-Faba O; Witjes JA; Van der Heijden AG; Medina R; Conde JM; Marberger M; Schmidbauer J; Fernández PL; Alcaraz A
    Eur J Cancer; 2016 Feb; 54():131-138. PubMed ID: 26761785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
    Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer.
    Trenti E; Pycha S; Mian C; Schwienbacher C; Hanspeter E; Kafka M; Spedicato GA; Vjaters E; Degener S; Pycha A; D'Elia C
    Cancer Cytopathol; 2020 May; 128(5):341-347. PubMed ID: 31977131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
    Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer.
    Ren S; Ren XD; Guo LF; Qu XM; Shang MY; Dai XT; Huang Q
    J Clin Lab Anal; 2020 Aug; 34(8):e23321. PubMed ID: 32281142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma.
    Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T
    Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
    Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary mRNA biomarker panel for the detection of urothelial carcinoma.
    Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S
    Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer.
    Huang S; Kou L; Furuya H; Yu C; Goodison S; Kattan MW; Garmire L; Rosser CJ
    Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1361-6. PubMed ID: 27383773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
    Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
    Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.